Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis

Hyun Jung Cho, Won Jung Koh, Yon Ju Ryu, Chang Seok Ki, Myung-Hyun Nam, Jong Won Kim, Soo Youn Lee

Research output: Contribution to journalArticle

122 Citations (Scopus)

Abstract

Antituberculosis drug-induced hepatitis attributed to isoniazid (INH) is one of the most prevalent drug-induced liver injuries. INH is metabolized by hepatic N-acetyltransferase (NAT) and cytochrome P450 2E1 (CYP2E1) to form hepatotoxins. The aim of this study was to evaluate whether polymorphisms of the NAT2 and/or CYP2E1 genes were associated with antituberculosis drug-induced hepatotoxicity in Korean patients. A total of 132 patients with tuberculosis who received antituberculosis treatment were followed prospectively. Their NAT2 and CYP2E1 genotypes were determined using polymerase chain reaction (PCR) with or without sequencing. Eighteen (13.6%) patients developed antituberculosis drug-induced hepatotoxicity. Regarding NAT2, slow acetylators had a higher incidence of hepatotoxicity than rapid acetylators (36.8% vs. 9.7%, P=0.005) and there was a 3.8-fold risk of hepatotoxicity for the slow acetylators compared to the rapid acetylators. For the CYP2E1 gene, the RsaI polymorphism in the 5′ untranslated region, and a polymorphic repetitive sequence at the CYP2E1 5′-flaking region were analyzed; there was no significant association between any CYP2E1 genotype and antituberculosis drug-induced hepatotoxicity. In conclusion, slow acetylator status of NAT2 was a significant susceptibility risk factor for antituberculosis drug-induced hepatotoxicity; NAT2 genotyping may be a useful tool for predicting antituberculosis drug-induced hepatotoxicity.

Original languageEnglish
Pages (from-to)551-556
Number of pages6
JournalTuberculosis
Volume87
Issue number6
DOIs
Publication statusPublished - 2007 Nov 1

Fingerprint

Cytochrome P-450 CYP2E1
Genetic Polymorphisms
Pulmonary Tuberculosis
Pharmaceutical Preparations
Chemical and Drug Induced Liver Injury
Genotype
Acetyltransferases
Nucleic Acid Repetitive Sequences
5' Untranslated Regions
Isoniazid
Genes
Tuberculosis
Polymerase Chain Reaction
Liver
Incidence

Keywords

  • CYP2E1
  • Hepatotoxicity
  • Isoniazid
  • Korean
  • NAT2

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis. / Cho, Hyun Jung; Koh, Won Jung; Ryu, Yon Ju; Ki, Chang Seok; Nam, Myung-Hyun; Kim, Jong Won; Lee, Soo Youn.

In: Tuberculosis, Vol. 87, No. 6, 01.11.2007, p. 551-556.

Research output: Contribution to journalArticle

Cho, Hyun Jung ; Koh, Won Jung ; Ryu, Yon Ju ; Ki, Chang Seok ; Nam, Myung-Hyun ; Kim, Jong Won ; Lee, Soo Youn. / Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis. In: Tuberculosis. 2007 ; Vol. 87, No. 6. pp. 551-556.
@article{4258a4d4bce041789dd5c96dfff98afc,
title = "Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis",
abstract = "Antituberculosis drug-induced hepatitis attributed to isoniazid (INH) is one of the most prevalent drug-induced liver injuries. INH is metabolized by hepatic N-acetyltransferase (NAT) and cytochrome P450 2E1 (CYP2E1) to form hepatotoxins. The aim of this study was to evaluate whether polymorphisms of the NAT2 and/or CYP2E1 genes were associated with antituberculosis drug-induced hepatotoxicity in Korean patients. A total of 132 patients with tuberculosis who received antituberculosis treatment were followed prospectively. Their NAT2 and CYP2E1 genotypes were determined using polymerase chain reaction (PCR) with or without sequencing. Eighteen (13.6{\%}) patients developed antituberculosis drug-induced hepatotoxicity. Regarding NAT2, slow acetylators had a higher incidence of hepatotoxicity than rapid acetylators (36.8{\%} vs. 9.7{\%}, P=0.005) and there was a 3.8-fold risk of hepatotoxicity for the slow acetylators compared to the rapid acetylators. For the CYP2E1 gene, the RsaI polymorphism in the 5′ untranslated region, and a polymorphic repetitive sequence at the CYP2E1 5′-flaking region were analyzed; there was no significant association between any CYP2E1 genotype and antituberculosis drug-induced hepatotoxicity. In conclusion, slow acetylator status of NAT2 was a significant susceptibility risk factor for antituberculosis drug-induced hepatotoxicity; NAT2 genotyping may be a useful tool for predicting antituberculosis drug-induced hepatotoxicity.",
keywords = "CYP2E1, Hepatotoxicity, Isoniazid, Korean, NAT2",
author = "Cho, {Hyun Jung} and Koh, {Won Jung} and Ryu, {Yon Ju} and Ki, {Chang Seok} and Myung-Hyun Nam and Kim, {Jong Won} and Lee, {Soo Youn}",
year = "2007",
month = "11",
day = "1",
doi = "10.1016/j.tube.2007.05.012",
language = "English",
volume = "87",
pages = "551--556",
journal = "Tuberculosis",
issn = "1472-9792",
publisher = "Churchill Livingstone",
number = "6",

}

TY - JOUR

T1 - Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis

AU - Cho, Hyun Jung

AU - Koh, Won Jung

AU - Ryu, Yon Ju

AU - Ki, Chang Seok

AU - Nam, Myung-Hyun

AU - Kim, Jong Won

AU - Lee, Soo Youn

PY - 2007/11/1

Y1 - 2007/11/1

N2 - Antituberculosis drug-induced hepatitis attributed to isoniazid (INH) is one of the most prevalent drug-induced liver injuries. INH is metabolized by hepatic N-acetyltransferase (NAT) and cytochrome P450 2E1 (CYP2E1) to form hepatotoxins. The aim of this study was to evaluate whether polymorphisms of the NAT2 and/or CYP2E1 genes were associated with antituberculosis drug-induced hepatotoxicity in Korean patients. A total of 132 patients with tuberculosis who received antituberculosis treatment were followed prospectively. Their NAT2 and CYP2E1 genotypes were determined using polymerase chain reaction (PCR) with or without sequencing. Eighteen (13.6%) patients developed antituberculosis drug-induced hepatotoxicity. Regarding NAT2, slow acetylators had a higher incidence of hepatotoxicity than rapid acetylators (36.8% vs. 9.7%, P=0.005) and there was a 3.8-fold risk of hepatotoxicity for the slow acetylators compared to the rapid acetylators. For the CYP2E1 gene, the RsaI polymorphism in the 5′ untranslated region, and a polymorphic repetitive sequence at the CYP2E1 5′-flaking region were analyzed; there was no significant association between any CYP2E1 genotype and antituberculosis drug-induced hepatotoxicity. In conclusion, slow acetylator status of NAT2 was a significant susceptibility risk factor for antituberculosis drug-induced hepatotoxicity; NAT2 genotyping may be a useful tool for predicting antituberculosis drug-induced hepatotoxicity.

AB - Antituberculosis drug-induced hepatitis attributed to isoniazid (INH) is one of the most prevalent drug-induced liver injuries. INH is metabolized by hepatic N-acetyltransferase (NAT) and cytochrome P450 2E1 (CYP2E1) to form hepatotoxins. The aim of this study was to evaluate whether polymorphisms of the NAT2 and/or CYP2E1 genes were associated with antituberculosis drug-induced hepatotoxicity in Korean patients. A total of 132 patients with tuberculosis who received antituberculosis treatment were followed prospectively. Their NAT2 and CYP2E1 genotypes were determined using polymerase chain reaction (PCR) with or without sequencing. Eighteen (13.6%) patients developed antituberculosis drug-induced hepatotoxicity. Regarding NAT2, slow acetylators had a higher incidence of hepatotoxicity than rapid acetylators (36.8% vs. 9.7%, P=0.005) and there was a 3.8-fold risk of hepatotoxicity for the slow acetylators compared to the rapid acetylators. For the CYP2E1 gene, the RsaI polymorphism in the 5′ untranslated region, and a polymorphic repetitive sequence at the CYP2E1 5′-flaking region were analyzed; there was no significant association between any CYP2E1 genotype and antituberculosis drug-induced hepatotoxicity. In conclusion, slow acetylator status of NAT2 was a significant susceptibility risk factor for antituberculosis drug-induced hepatotoxicity; NAT2 genotyping may be a useful tool for predicting antituberculosis drug-induced hepatotoxicity.

KW - CYP2E1

KW - Hepatotoxicity

KW - Isoniazid

KW - Korean

KW - NAT2

UR - http://www.scopus.com/inward/record.url?scp=35348922264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348922264&partnerID=8YFLogxK

U2 - 10.1016/j.tube.2007.05.012

DO - 10.1016/j.tube.2007.05.012

M3 - Article

C2 - 17950035

AN - SCOPUS:35348922264

VL - 87

SP - 551

EP - 556

JO - Tuberculosis

JF - Tuberculosis

SN - 1472-9792

IS - 6

ER -